Comparison of two standard chemotherapy regimens for good-prognosis germ-cell tumors: Updated analysis of a randomized trial with 8 years follow-up.

Abstract

5016 Background: We performed a multicentre randomised trial for good-prognosis germ-cell tumours of two standard chemotherapy regimens containing bleomycin (B), etoposide (E) and cisplatin (P). Accrual was stopped early, after interim analysis with a median follow-up of 33 months found a survival benefit for the regimen similar to Indiana University BEP… (More)

Topics

Cite this paper

@article{Grimison2009ComparisonOT, title={Comparison of two standard chemotherapy regimens for good-prognosis germ-cell tumors: Updated analysis of a randomized trial with 8 years follow-up.}, author={Peter Scott Grimison and Martin Richard Stockler and Damien B. Thomson and Ian N. Olver and Vernon Harvey and Howard Gurney and Craig Lewis and Val Gebski and Amy L Boland and G C Toner}, journal={Journal of clinical oncology : official journal of the American Society of Clinical Oncology}, year={2009}, volume={27 15_suppl}, pages={5016} }